Open-label Study of Curcumin C-3 Complex in Schizophrenia

Clinical trial NCT01875822 · COMPLETED

Trial details

NCT number: NCT01875822
Sponsor: Woodbury, Michel, M.D.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Depression

Start date: 2009-06-01
Primary completion: 2011-10-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.